HDI Publications by date
Using the Search: Choose a publication year, then use search to find papers within that year. No results? The paper may have been published in a different year — try selecting another year and searching again.
Clinical characteristics, treatments and outcomes in patients diagnosed with hepatocellular carcinoma (HCC) receiving locoregional treatment in England
Blak BT, Sharma R, Zalin-Miller A, Jose S, Mare SL.
Clinical characteristics, treatments and outcomes in patients diagnosed with hepatocellular carcinoma (HCC) receiving locoregional treatment in England. EASL …
Sebaceous carcinoma epidemiology, associated malignancies and Lynch/Muir-Torre syndrome screening in England from 2008 to 2018
Cook S, Pethick J, Kibbi N, Hollestein L, Lavelle K, de Vere Hunt I, Turnbull C, Rous B, Husain A, Burn J, Lüchtenborg M, Santaniello F, McRonald F, Hardy S, Linos E, Venables Z, Rajan N.
Background
Sebaceous …
Long-term health outcomes of bilateral salpingo-oophorectomy in women with personal history of breast cancer
Hend Hassan; Tameera Rahman; Andrew Bacon; Craig Knott; Isaac Allen; Catherine Huntley; Lucy Loong; Yvonne Walburga; Katrina Lavelle; Eva Morris; Steven Hardy; Bethany Torr; Diana M Eccles; Clare Turnbull; Marc …
Amivantamab Versus Alternative Real-World Anti-Cancer Therapies in Patients with Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Exon 20 Insertion Mutations in the US and Europe
Girard N, Wolf J, Kim TM, Leighl N, Knott CS, Li T, Cabrieto J, Diels J, Sermon J, Mahadevia P, Schioppa CA, Sabari J.
Amivantamab Versus Alternative Real-World Anti-Cancer Therapies in Patients with Advanced …
Trends in incidence, treatment and survival of Merkel cell carcinoma epidemiology in England 2004-2018
Mistry K, Levell NJ, Hollestein, Wakkee M, Hijsten T, Knott CS, et al.
Abstract:
Introduction: Patients with advanced, epidermal growth factor receptor (EGFR)-mutated, non-small cell lung cancer (NSCLC) with …
An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations
Chouaid, C., Bosquet, L., Girard, N. et al.
Introduction:
Patients with advanced, epidermal growth factor receptor (EGFR)-mutated, non-small cell lung cancer (NSCLC) with Exon20 insertion mutations (Exon20ins) …
Germline mismatch repair (MMR) gene analyses from English NHS regional molecular genomics laboratories 1996–2020
Lucy Loong, Catherine Huntley, Fiona McRonald, Francesco Santaniello, Joanna Pethick, Bethany Torr, Sophie Allen, Oliver Tulloch, Shilpi Goel, Brian Shand, Tameera Rahman, Margreet Luchtenborg, Alice Garrett, …
Cohort profile of the Sloane Project: methodology for a prospective UK cohort study of >15 000 women with screen-detected non-invasive breast neoplasia.
Clements K, Dodwell D, Hilton B, Stevens-Harris I, Pinder S, Wallis MG, et al.
Abstract:
Purpose The introduction of breast screening in the UK led to an increase in the detection of non-invasive breast …
Second primary cancer risks for female and male breast cancer survivors
Isaac Allen; Tameera Rahman; Andrew Bacon; Craig Knott; Sophie Jose; Sally Vernon; Hend Hassan; Catherine Huntley; Lucy Loong; Yvonne Walburga; Katrina Lavelle; Eva Morris; Steven Hardy; Beth Torr; Diana Eccles; …
Amivantimab versus real-world clinical practice in Europe and the US for patients with advanced non-small cell lung cancer with activating epidermal growth factor receptor exon 20 insertion mutations
Girard N, Wolf J, Kron A, Scheffler M, Knott CS Bosquet L et al.
Amivantimab versus real-world clinical practice in Europe and the US for patients with advanced non-small cell lung cancer with activating …
Characteristics, treatment patterns and outcomes of patients with newly diagnosed advanced ovarian cancer (aOC) in England
Angela Whittle, Betina Blak, Amy Zalin-Miller, Orlaith Condon (2022)
‘Characteristics, treatment patterns and outcomes of patients with newly diagnosed advanced ovarian cancer (aOC) in England’; abstract …
The presentation, management and outcome of patients with ductal carcinoma in situ (DCIS) with microinvasion (invasion ≤1 mm in size)—results from the UK Sloane Project.
Shaaban AM, Hilton B, Clements K, Dodwell D, Sharma N, Kirwan C, et al.
Abstract:
Background
The diagnosis, management and prognosis of microinvasive breast carcinoma remain controversial.
Methods
We analysed the …
No results found.